Le Lézard
Classified in: Health, Covid-19 virus
Subjects: PSF, CFG

Statement from Minister Duclos on first cases of Omicron variant of concern in Canada

OTTAWA, ON, Nov. 28, 2021 /CNW/ - "I was informed today by the Public Health Agency of Canada that testing and monitoring of COVID-19 cases has confirmed two cases of the Omicron variant of concern in Ontario.

This development demonstrates that our monitoring system is working.

I have spoken with my provincial counterpart in Ontario whose public health officials are working provincially and locally to contact and trace the cases.

As the monitoring and testing continues with provinces and territories, it is expected that other cases of this variant will be found in Canada.

I know that this new variant may seem concerning, but I want to remind Canadians that vaccination, in combination with public health and individual protective measures, is working to reduce the spread of COVID-19 and its variants in our communities.

On November 26, in response to concerns about the Omicron variant of concern, I announced that the Government of Canada implemented enhanced border measures for all travellers who have been in the Southern Africa region ? including South Africa, Eswatini, Lesotho, Botswana, Zimbabwe, Mozambique, and Namibia? within the last 14 days before arriving in Canada, until January 31, 2022.

These border measures are being implemented while the Canadian and global medical, public health and research communities actively evaluate this variant ? as has been done with previous variants -- to better understand the potential implications in terms of transmission, clinical presentation and vaccine efficacy.

The Government of Canada will continue to assess the evolving situation and I will provide updates as we have them."

SOURCE Public Health Agency of Canada

These press releases may also interest you

at 04:00
Based in Augusta, Georgia, USA, Jinfiniti Precision Medicine is dedicated to increasing human health and lifespan by providing a range of rapid screening services to biomedical research institutions, nutraceutical companies, the longevity industry,...

at 04:00
The Celiac Disease Foundation, the nation's leading patient advocacy organization for celiac disease, announces its newest appointee, Casey Guber, to its Board of Directors. The officers for 2022 are Chair Adrienne Bender, Vice Chair John Wagner,...

at 03:46
Mentice AB (STO: MNTC) announces that the company will present its year-end report via a webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg and CFO Gunilla Andersson. To register for the...

at 03:41
Apollon Formularies plc (AQSE: APOL) ("Apollon" or the "Company"), a UK based international medical cannabis pharmaceutical company trading on AQSE Growth Market, is pleased to announce the appointment of Dr. Herbert Fritsche to the Board of...

at 03:01
Nova Mentis Life Science Corp. ("NOVA" or the "Company"), a biotechnology company and global leader in first-in-class psilocybin-based therapeutics and complementary diagnostics for neuroinflammatory disorders is proud to announce that the Company...

at 03:00
SiSaf Ltd, a company developing RNA therapeutics for rare genetic skeletal disorders, today announced that it has appointed Professor Michael J. Econs, MD as Clinical Advisor. Distinguished Professor of Medicine and Medical and Molecular Genetics at...

News published on 28 november 2021 at 17:06 and distributed by: